As featured in

About Blynksolve

Blynksolve is a pharmaceutical technology company dedicated to advancing operational clarity and manufacturing excellence in GMP-regulated environments. Our platform enables pharmaceutical teams to unify process data, institutional knowledge, and operational oversight - within a framework designed to meet the highest standards of compliance and performance. Purpose-built for the pharmaceutical sector, Blynksolve provides a digital twin environment that enhances visibility, accelerates decision-making, and supports consistent execution across teams and sites. Our approach is grounded in industry experience, regulatory understanding, and a deep appreciation for the realities of modern manufacturing operations. We work with leading pharma manufacturers who recognize the need for more agile, data-enabled operations - and who value solutions that integrate smoothly with existing infrastructure while enabling measurable improvements in efficiency, quality, and compliance.

Our Vision

Pharmaceutical manufacturing today faces increasing pressure to deliver faster, operate more efficiently, and ensure audit readiness at every turn. At the same time, the systems supporting operations - tools for data analysis, knowledge transfer, and cross-functional collaboration - often remain fragmented, manual, or insufficiently scalable.

Blynksolve was founded on the principle that better performance starts with better clarity. We believe the ability to connect data with context, and people with process, is essential to resilient and forward-looking manufacturing. Our vision is to support the industry's evolution by enabling a more intelligent, integrated, and knowledge-driven approach to operations. By delivering tools that enhance transparency, reduce friction, and ensure data integrity, Blynksolve helps organizations achieve continuous improvement and confidently navigate the path toward digital maturity. This is not about transformation for its own sake - it's about providing pragmatic, compliant, and effective solutions that meet the realities of pharmaceutical production today, and tomorrow.

Letter from our CEO

Before starting Blynksolve, I worked as a process engineer at Pfizer and MSD, where I led tech transfers, supported chromatography start-ups, and lived the daily pressure of batch timelines, data hunts, and regulatory scrutiny. Like many in pharma, I often found myself spending more time wrangling spreadsheets than solving process problems. I've been the engineer stuck chasing data across disconnected systems. I've felt the friction of tribal knowledge during tech transfers and the frustration of redoing work because information wasn't captured properly the first time. Those challenges didn't just slow us down - they introduced risk and inefficiency into some of the most tightly controlled environments in the world.

That's what drove me to build Blynksolve.

We're not just another software company. Blynksolve is built by people who've been on the plant floor - who know that GMP manufacturing demands both precision and practicality. Our platform combines real-time analytics and collaborative process design in a way that's intuitive, compliant, and fast to deploy. With blynkInsights and blynkDesign, we give teams a smarter way to monitor, troubleshoot, and share critical process knowledge - so they can make faster decisions and deliver better outcomes.

Thanks for taking the time to learn about Blynksolve. If you've ever thought, “There has to be a better way” - you're not alone. We built this for you.

Peter Blennerhassett

CEO, Blynksolve